NADETECT
Dead / Abandoned — Abandoned — failure to respond (as of 09 Jun 2022)
What this means for you
This application is over — abandoned 17 May 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90608789
- Mark type
- Stylized text
- Filed
- 29 Mar 2021
- Abandoned
- 17 May 2022
- Attorney of record
- Taylor M Curtis
Goods and services
- Class 005 — Pharmaceuticals: Metabolism assay used to stratify patients in trials; small molecules intended to target multiple nodes in NAD synthesis pathways identify and characterize altered states of NAD metabolism; drugs and therapies that target NAD metabolism defects in cancer
Owner
- ALPHINA THERAPEUTICS, INC., WESTPORT, CT, US
- Athena Therapeutics LLC, Westport, CT, US
Prosecution history
- 09 Jun 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 09 Jun 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 15 Nov 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 15 Nov 2021 — NON-FINAL ACTION E-MAILED
- 15 Nov 2021 — NON-FINAL ACTION WRITTEN
- 08 Nov 2021 — ASSIGNED TO EXAMINER
- 20 Oct 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Jul 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Apr 2021 — NEW APPLICATION ENTERED